Europe Archives - Page 63 of 93 - Journal for Clinical Studies

Current Edition

Europe

Oral semaglutide demonstrated significant reduction in blood sugar vs placebo in PIONEER 1 trial

Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood sugar versus placebo in adults with type 2 ...

27 June 2018 Europe blood | demonstrated

Continue Reading →

Europe

NANOBIOTIX ANNOUNCES POSITIVE PHASE II/III TOPLINE DATA IN SOFT TISSUE SARCOMA WITH NBTXR3

Trial achieved its primary endpoint of pathological Complete Response Rate Trial achieved its secondary endpoint in operability (R0 rate) NBTXR3 demonstrat...

27 June 2018 Europe announces | data

Continue Reading →

Europe

Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson’s Disease Published in JAMA Neurology

Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience categor...

20 June 2018 Europe announces | clinical

Continue Reading →

Europe

Clinical trial targets metastatic colorectal cancer with new combination therapy

Rutgers Cancer Institute of New Jersey is offering a clinical trial targeting an advanced form of colorectal cancer with a combination vaccine/immunotherapy drug trea...

20 June 2018 Europe cancer | clinical

Continue Reading →

Europe

TrialScope Selected by Leading Global Pharmaceutical Company to Support Clinical Trial Disclosure and Transparency

TrialScope, the global software leader in clinical trial transparency and compliance solutions, today announced that it has been selected by GlaxoSmithKline plc to ...

20 June 2018 Europe company | global

Continue Reading →

Europe

Cannabidiol shows promise alongside conventional epilepsy medication in Lennox-Gastaut Syndrome

The use of medical cannabis to treat seizures has been in the news a lot this week due to the current case involving 12-year old Billy Caldwell. Last month, a study...

20 June 2018 Europe cannabidiol | convenional

Continue Reading →

Europe

Aminex Therapeutics Initiates First Clinical Trial of Novel Immunotherapy AMXT 1501 + DFMO in Cancer Patients

Polyamine depletion therapy represents a unique cancer immunotherapy approach Aminex Therapeutics, Inc., a clinical-stage drug development company focused on advanc...

20 June 2018 Europe Aminex | clinical

Continue Reading →

Europe

LUNGevity Takes Step Forward in Clinical Trial Eligibility Reform for Lung Cancer Patients

LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, is pleased to announce the publication of recommendations that will create more...

20 June 2018 Europe clinical | eligibility

Continue Reading →

Europe

CytoDyn Provides Update on Phase 2 Clinical Trial with PRO 140 in GvHD

Patient enrollment proceeding under amended protocol CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company developing new antibody therapies for combating human immuno...

20 June 2018 Europe clinical | CytoDyn

Continue Reading →

Europe

Iceland’s Cohort Saga Selects SMART-TRIAL Software for a Decade-Long Study on how Trauma Impacts Women’s Health

SMART-TRIAL software will be used in a large nationwide research project where 110,000 Icelandic women are invited to participate The SAGA cohort is one of the large...

20 June 2018 Europe cohort | Iceland

Continue Reading →